Roger Jeffs - Chapel Hill NC, US David Zaccardelli - Cary NC, US
International Classification:
A01N 59/00 A61K 31/192 A01P 1/00 A01N 37/44
US Classification:
424722, 514569, 514561
Abstract:
Buffer solutions for pharmaceutical preparations that have bactericidal activity preferentially against gram negative bacteria are provided. The buffers have a pH of greater than about 10 or less than about 4.5 with low buffer capacity. Methods of their use in reducing the occurrence of blood stream infections in a mammal is also provided.
Buffer Solutions Having Selective Bactericidal Activity Against Gram Negative Bacteria And Methods Of Using Same
Buffer solutions for pharmaceutical preparations that have bactericidal activity preferentially against gram negative bacteria are provided. The buffers have a pH of greater than about 10 or less than about 4.5 with low buffer capacity. Methods of their use in reducing the occurrence of blood stream infections in a mammal is also provided.
Buffer Solutions Having Selective Bactericidal Activity Against Gram Negative Bacteria And Methods Of Using Same
Buffer solutions for pharmaceutical preparations that have bactericidal activity preferentially against gram negative bacteria are provided. The buffers have a pH of greater than about 10 or less than about 4.5 with low buffer capacity. Methods of their use in reducing the occurrence of blood stream infections in a mammal is also provided.
Buffer Solutions Having Selective Bactericidal Activity Against Gram Negative Bacteria And Methods Of Using Same
- Silver Spring MD, US David Zaccardelli - Cary NC, US
Assignee:
United Therapeutics Corporation - Silver Spring MD
International Classification:
A61K 47/18
US Classification:
514569
Abstract:
Buffer solutions for pharmaceutical preparations that have bactericidal activity preferentially against gram negative bacteria are provided. The buffers have a pH of greater than about 10 or less than about 4.5 with low buffer capacity. Methods of their use in reducing the occurrence of blood stream infections in a mammal is also provided.
Name / Title
Company / Classification
Phones & Addresses
David Zaccardelli President
MDS Tricon Pharma Svc Pharmaceutical Consultants
5415 W Laurel St, Tampa, FL 33607 (813)2860404, (813)2861105
David Zaccardelli
PHARMACEUTICAL DEVELOPMENT CORPORATION
5415 W Laurel St, Tampa, FL 33607
David S. Zaccardelli Director
Tricon Pharmaceutical Development Services, LLC Industrial Building Construction
6226 Wild Orchid Dr, Lithia, FL 33547
David Zaccardelli Principal
Tricon Pharmaceuticals Business Services at Non-Commercial Site · Nonclassifiable Establishments
100 Regal Pne Ct, Cary, NC 27518
David S. Zaccardelli Chairman, President, Director